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Abstract: This study used toxicogenomics to identify the complex biological response of human
lung BEAS-2B cells treated with organic components of particulate matter in the exhaust of a diesel
engine. First, we characterized particles from standard diesel (B0), biodiesel (methylesters of rapeseed
oil) in its neat form (B100) and 30% by volume blend with diesel fuel (B30), and neat hydrotreated
vegetable oil (NEXBTL100). The concentration of polycyclic aromatic hydrocarbons (PAHs) and their
derivatives in organic extracts was the lowest for NEXBTL100 and higher for biodiesel. We further
analyzed global gene expression changes in BEAS-2B cells following 4 h and 24 h treatment with
extracts. The concentrations of 50 µg extract/mL induced a similar molecular response. The common
processes induced after 4 h treatment included antioxidant defense, metabolism of xenobiotics
and lipids, suppression of pro-apoptotic stimuli, or induction of plasminogen activating cascade;
24 h treatment affected fewer processes, particularly those involved in detoxification of xenobiotics,
including PAHs. The majority of distinctively deregulated genes detected after both 4 h and 24 h
treatment were induced by NEXBTL100; the deregulated genes included, e.g., those involved in
antioxidant defense and cell cycle regulation and proliferation. B100 extract, with the highest PAH
concentrations, additionally affected several cell cycle regulatory genes and p38 signaling.
Keywords: diesel; alternative fuels; diesel exhaust particles; organic extracts; gene expression profiles
1. Introduction
Diesel engines are popular not only for trucks but also in passenger cars and a wide range of
mobile machinery due to lower fuel consumption and consequently lower CO2 emissions, relatively
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low production and operating costs, reliability, and overall practicality. Awareness of global climate
change and the need to reduce CO2 emissions have led to renewable diesel fuels with significantly
lower emissions of fossil carbon (as CO2) compared to conventional fossil diesel fuels. Drop-in
replacement fuels for existing diesel engines are typically produced from vegetable oils and other
fatty acids, either by transesterification into n-alkyl-esters of fatty acids, called biodiesel (in the EU,
typically rapeseed oil methylesters), or by thermal hydrodeoxynation or similar processes into mostly
paraffinic fuels, termed hydrotreated vegetable oil (HVO). The chemical composition and properties of
renewable diesels are dependent on the production technique; e.g., biodiesel is enriched with oxygen
in comparison with HVO and conventional diesel, biodiesel and HVO lack sulfur and do not contain
aromatic hydrocarbons as diesel [1,2].
Renewable diesel fuels produce less particulate matter, carbon monoxide and total hydrocarbons
due to reduced aromatics content, higher cetane number (HVO), or oxygen content (biodiesel); the
same property, however, could lead to higher emissions of nitrogen oxides (NOx) [3–8]. A disadvantage
specific for biodiesel is its lower energy density, leading to a higher fuel consumption and a decrease
in torque and power at full load conditions [9]. HVO, however, has no or minor negative influence on
fuel consumption and engine power [3,10]. Particle number size distributions were mostly shifting
toward smaller sizes with an increased portion of biodiesel in the fuel [4,11]. All presented emission
patterns for biodiesel strongly depend on operating regime and engine type, therefore there are also
opposite findings, e.g., an increase in particulate mass during idling on biodiesel [12] or opposite
results in particle number concentrations in exhaust between two engines under the same conditions
on the same biodiesel/diesel mixtures [13].
Diesel exhaust, along with air pollution, was categorized by the International Agency for Research
on Cancer (IARC) as carcinogenic to humans [14,15]. However, the different chemical composition
of diverse blends of diesel and renewable fuels also influences exhaust emission characteristics.
In recent years, more attention has been paid to diesel exhaust particles (DEP) (reviewed in [16]),
as DEP is a carrier of polycyclic aromatic hydrocarbons (PAHs) that exert most of the genotoxic
activity. Benzo[a]pyrene (BaP) is carcinogenic to humans and several other PAHs have been classified
as probable or possible human carcinogens [14]. Although secondary genotoxicity elicited by the
interaction of the particles with the immune system resulting in inflammation is believed to be an
important factor in the negative health effects of DEP exposure [17], primary genotoxicity directly
caused by organic compounds adsorbed onto DEP may substantially contribute to the carcinogenicity
of DEP. As the content of PAHs between different fuels’ DEPs varies, the genotoxicity of their organic
extracts also depends on the fuel used [12,18]. It has been reported that toxic effects of DEP and DEP
extracts from identical fuels differ [19,20]. Therefore, ideally, a battery of tests including both particles
and extracts should be applied. However, to specifically reveal the potential carcinogenic effects of
PAHs, application of organic extracts is more relevant. Although the genotoxicity of DEP extracts
may be easily tested by standardized, well-established tests including cytotoxicity measurement [20],
Ames test [20,21], analysis of double strand DNA breaks [21], apoptosis, frequency of micronuclei [22],
bulky DNA adducts formation or oxidative DNA damage [12], for a comprehensive assessment of the
biological processes induced by the DEP extracts the treatment of the whole genome gene expression
analysis is a valuable tool.
The objective of the present study was to compare the toxicity of organic compound mixtures
extracted from DEPs produced by diverse fuels (conventional fossil diesel, 100% biodiesel, a blend
of diesel/biodiesel and HVO) with the special focus on characterization of the complex cellular
response. A fuel marketed as “renewable diesel” under the name of NEXBTL (Neste Oil, Espoo,
Finland) was used as a HVO representative. An IVECO Tector 5.9 L, 176 kW engine was used to
generate DEPs as it is commonly used in the EU in smaller trucks. We aimed to investigate the
whole-genome gene expression changes following the exposure to organic compounds extracted from
different diesel/renewable diesel fuel exhaust particles and to reveal common genes and processes
similarly affected upon all DEP extracts treatment as well as the specific molecular signatures linked
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to the activity of individual extracts. A detailed chemical analysis of PAHs and their derivatives was
employed to clarify the differences in toxicity of individual extracts. To support gene expression data,
the oxidative potential of DEP extracts was evaluated by intracellular reactive oxygen species (ROS)
assay and glutathione assay upon 4 h exposure and expressions of selected genes were confirmed
by RT-qPCR.
2. Results
2.1. Characteristics of Collected Exhaust Particles; Chemical Analysis of Organic Extracts
Figure 1A shows particle number distributions for individual fuels. Although the size of
most of the DEPs for all fuels was between 25 and 100 nm, B100 also generated a substantial
amount of particles smaller than 10 nm. The total mass of particles emitted, calculated per kg
of fuel, differed among diesel, biodiesel and NEXBTL100 (Figure 1B). While standard diesel fuel
generated more than 11 mg particles/kg, for B100 the production was almost halved (6 mg/kg).
NEXBTL100 and B30 fuels produced similar amount of particles (8.2 and 8.7 mg/kg, respectively).
Next, we determined the content of PAHs and their derivatives in dichloromethane extracts of
DEPs from individual fuels. In general, the content of PAHs was the lowest in the NEXBTL100
extract and highest in the extracts from DEPs from fuels containing biodiesel (B30 or B100) (Table 1).
The sum of PAH concentrations classified by IARC as carcinogenic, or probably/possibly carcinogenic
to humans (c-PAHs; Group 1, 2A or 2B) including benzo[a]pyrene, benz[a]anthracene, chrysene,
benzo[b]fluoranthene, benzo[k]fluoranthene, dibenz[a,h]anthracene, and indeno[1,2,3-cd]pyrene,
expressed in ng of cPAH per mg of particulate matter, ranged from 7.5 ng/mg for NEXBTL100
to 51.7 ng/mg for B100. Interestingly, although concentrations of most of the c-PAHs were lowest in
the NEXBTL100 extract, this was not confirmed for BaP, a known human carcinogen. On the other
hand, high concentrations of low-molecular-weight PAHs fluoranthene and pyrene were found in the
B30 and B100 extracts (Table 1).
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Table 1. Results of chemical analysis.
PAHs
Compound (ng/mg DEP) B0 B30 B100 NEXBTL100
Fluoranthene 41.9 110 117 39.4
Pyrene 67.7 152 144 43.1
Benz[a]anthracene * 6.6 9.8 26.1 5.0
Chrysene * 5.1 6.0 12.5 1.0
Benzo[b]fluoranthene * 1.2 1.4 7.0 0.3
Benzo[k]flu ranthene * n.d. n.d. 2.6 n.d.
Benzo[a]pyrene * 0.6 0.9 1.7 1.2
Benzo[g,h,i]perylene 2.2 2.8 3.8 2.0
Dibenz[a,h]anthracene * n.d. n.d. n.d. n.d.
Indeno[1,2,3-cd]pyrene * 0.7 0.8 1.8 n.d.
4H-Cyclopenta[d,e,f]phenathrene 2.8 3.8 4.3 9.4
Benzo[c]phenanthrene 1.9 3.8 4.0 1.3
Benzo[j]fluoranthene 2.4 2.8 6.4 2.0
Benzo[e]pyrene 0.7 0.6 3.6 0.3
Triphenylene 9.0 3.6 4.0 1.1
Benzo[c]chrysene n.d. n.d. 0.2 n.d.
Coronene 0.8 0.7 0.7 0.6
Methylated PAHs
Compound (ng/mg DEP) B0 B30 B100 NEXBTL100
1-Methylpyrene 5.1 7.2 3.9 1.4
2-Methylpyrene 8.5 11. 8.0 2.9
4-Methylpyrene 10.0 13.4 12 3.7
1-Methylchrysene 0.3 0.3 1.2 n.d.
7-Methylbenz[a]anthracene 0.3 n.d. n.d. 0.2
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Oxygenated PAHs
Compound (ng/mg DEP) B0 B30 B100 NEXBTL100
1,8-Naphthalic Anhydride 25.4 29.5 29.7 19.8
Phenanthrene-9,10-dione 1.3 0.8 0.8 0.5
9H-Fluoren-9-one 4.3 2.8 1.7 4.7
Anthrone n.d. n.d. n.d. n.d.
Anthracene-9,10-dione 2.7 4.5 4.0 2.6
7H-Benz[d,e]anthracene-7-one 1.4 1.5 2.4 0.28
9-Hydroxybenzo[a]pyrene 0.06 0.07 0.09 0.07
Benz[a]anthracene-7,12-dione 0.02 0.04 0.15 0.01
3-Hydroxybenzo[a]pyrene 0.05 0.05 0.10 0.02
Nitrated PAHs
Compound (pg/mg DEP) B0 B30 B100 NEXBTL100
1-Nitropyrene 314 539 1504 126
2-Nitropyrene 25.0 12.0 23.0 n.d.
4-Nitropyrene 18.0 16.0 44.0 10.0
3-Nitrofluoranthene 7.0 16.0 41.0 2.0
Dinitrated PAHs
Compound (pg/mg DEP) B0 B30 B100 NEXBTL100
1,3-Dinitropyrene 1.6 2.4 17.7 0.4
1,6-Dinitropyrene 1.2 5.6 65.0 n.d.
1,8-Dinitropyrene 0.9 4.6 48.0 n.d.
* Human carcinogens (IARC). PAHs, polycyclic aromatic hydrocarbons; DEP, diesel exhaust particles;
n.d., not detectable.
2.2. Cytotoxicity Assessment
Cytotoxicity was evaluated upon 24 h exposure using the WST-1 Proliferation Assay. The range
of concentrations from 22 µg/mL to 1000 µg/mL of each DEP extract was applied to obtain a
dose–response proliferation capacity of the cells. The results for individual extracts were expressed
as a percentage of increase/decrease of the potency to convert tetrazolium dye by mitochondrial
dehydrogenase enzymes compared to the untreated control (Figure 2). We detected a substantial
increase of absorbance up to the dose 68.7 µg/mL (154.5%–182.7%) while higher doses gradually
decreased the absorbance upon all DEP extract treatments. Dose 134.2 µg/mL already caused
inhibition of metabolic activity indicating decreased cell viability below the control level (95%–62.8%).
NEXBTL100 extract exhibited the highest but not significant rate of dye conversion up to the dose
134.2 µg/mL compared to other treatments, however, the rapid decrease at higher doses was
consequently observed. For all DEP extracts, a non-toxic concentration of 50 µg/mL was selected for
further testing.
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Figure 2. Cell viability evaluated by WST-1 Proliferation Assay. Cells were exposed to 18 different
concentrations of: (A) B0; (B) B30; (C) B100; and (D) NEXBTL100 extracts for 24 h and the results
were expressed as a percentage of increased/decreased activity of mitochondrial dehydrogenases to
metabolize tetrazolium dye compared to the untreated control.
2.3. Quantification of Intracellularly Generated Reactive Oxygen Species and Reduced Glutathione Level
We measured the oxidative potency of DEP extracts, intracellular ROS production and levels
of reduced glutathione in BEAS-2B cells. After 4 h incubation with 50 µg/mL dose of each DEP
extract, we did not observe any significant increase of fluorescence indicating ROS production. Instead,
NEXBTL100 and B30 rather slightly decreased (31% and 23%, respectively) ROS levels compared to
untreated controls. B100 exhibited a subtle increase (11%) and B0 had no effect (Figure 3). Similar
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to ROS production, we did not find significant changes in reduced glutathione (GSH) levels among
DEP-treated cells (Figure 4).Int. J. Mol. Sci. 2016, 17, 1833 7 of 24 
 
 
Figure 3. Relative intracellular ROS production upon 4 h exposure to DEP extract. Results are 
expressed as ratios of fluorescence intensity of treated and untreated cells. Cells were incubated with 
50 µg/mL of different DEP extracts and 250 µM tert-butyl hydroperoxide (TBHP) as a positive control. 
No significant changes between the samples treated with individual DEP extracts and the control 
sample were found. 
 
Figure 4. Relative GSH levels upon 4 h exposure to DEP extracts. Results are expressed as ratios of 
fluorescence intensity of treated and untreated cells. Cells were incubated with 50 µg/mL of different 
DEP extracts and staurosporine (1 µg/mL) as a positive control. No significant changes between the 
samples treated with individual DEP extracts and the control sample were found. 
2.4. Gene Expression Profiling in BEAS-2B Exposed to Diverse DEP Extracts 
2.4.1. Identification of Differentially Expressed Genes 
We performed differential gene expression analysis to explore the impact of DEP extract 
exposure on mRNA expression levels. Results showed that all DEP extracts induced significant 
changes in expression of various genes following both 4 and 24 h exposure. The number of 
upregulated and downregulated genes varied among all samples. After 4 h exposure, B100 extract 
elicited the most pronounced response and modulated the highest number of genes, while 
NEXBTL100 exhibited the lowest potency to induce gene expression changes. Interestingly, the 
number of deregulated genes increased with the increasing ratio of biocomponent in the fuel. After 
24 h exposure, B30 extract yielded an increase of considerably higher number of deregulated genes 
compared to other treatments. Similar to 4 h treatment, 24 h exposure to NEXBTL100 resulted in the 
weakest response in terms of gene numbers. Venn diagrams were generated to visualize the common 
Figure 3. Relative intracellular ROS production upon 4 h exposure to DEP extract. Results are expressed
as ratios of fluorescence intensity of treated and untreated cells. Cells were incubated with 50 µg/mL of
different DEP extracts and 250 µM tert-butyl hydroperoxide (TBHP) as a positive control. No significant
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e performed differ ntial gene expression analysis to explor the impact of DEP extract exposure
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expression of va ious genes following both 4 and 24 h exposure. The number of upregulated and
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pronounced response a d modulated the highest number of genes, while NEXBTL100 exhibited th
lowest potency to induce gene expression changes. Interestingly, the number of deregulated genes
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increased with the increasing ratio of biocomponent in the fuel. After 24 h exposure, B30 extract
yielded an increase of considerably higher number of deregulated genes compared to other treatments.
Similar to 4 h treatment, 24 h exposure to NEXBTL100 resulted in the weakest response in terms of gene
numbers. Venn diagrams were generated to visualize the common genes identically modulated by all
DEP extracts as well as unique transcripts affected by individual treatments. The analysis revealed
27 common genes deregulated following 4 h exposure (Figure 5A). Several genes were common for
other combinations of DEP extract treatments while each individual DEP extract induced a relatively
higher number of specifically deregulated genes (22 for B0, 36 for B30, 58 for B100 extract treatment and
27 genes for NEXBTL100). Twenty-four hour exposure resulted in deregulation of 19 genes common
for all treatments (Figure 5B). A substantially higher number of genes was modulated in response to
individual DEP extracts, particularly B30 induced changes in expression of 232 genes compared to
other extracts: NEXBTL100 extract induced deregulation of 15 genes; B0, 74 genes; and B100, 10 genes.
A list of differentially deregulated genes is included in Table S1.
Int. J. Mol. Sci. 2016, 17, 1833 8 of 24 
 
genes identically modulated by all DEP extracts as well as unique tran cripts affected by individua  
treatments. The analysis revealed 27 ommon genes deregulated following 4 h exposure (Figure 5A). 
Several ge es w re common for ther combinations of DEP extract tr atments while each individual 
DEP extract induced a relatively higher number of specifically deregulated genes (22 for B0, 36 for 
B30, 58 for B100 extra t treatment and 27 genes for NEXBTL100). Twenty-four hour exposure r sulte  
in d regulation of 19 genes common for all t atments (Figur  5B). A substantially higher number of 
genes was odulated in respon e to i dividual DEP extracts, particularly B30 induced changes in 
expression of 232 gene  compared to other extracts: NEXBTL100 extract induced deregulation of  
15 genes; B0, 74 genes; and B100, 10 genes. A list of differentially deregulated ge es is included in 
Table S1. 
(A) (B)
Figure 5. Venn diagrams illustrating the overlap of genes commonly modulated in response to all 
DEP extract treatments as well as numbers of specifically modulated genes by each individual DEP 
extract upon: (A) 4 h; and (B) 24 h incubation. 
2.4.2. Functional Analysis 
Commonly Modulated Pathways 
We performed functional analysis of significantly deregulated genes using the ToppFun tool to 
discover common processes and pathways identically modified by all DEP extract treatments.  
Table 2 shows the rank of pathways enriched in the list of 27 common genes deregulated after  
4 h exposure. The top represented pathway was “Benzo[a]pyrene metabolism” with aldo-keto 
reductases (AKRs) AKR1C3 and AKR1C2 as the most important contributing genes. It was the only 
pathway with significance below 0.05 after Bonferroni correction. However, numerous other 
pathways were found with high significance after False Discovery Rate Benjamini–Hochberg (FDR 
B&H) correction. AKR1C3 and AKR1C2 were further involved in “Synthesis of bile acids and bile salts 
via 27-hydroxycholesterol”, “Synthesis of bile acids and bile salts via 24-hydroxycholesterol”, 
“Synthesis of bile acids and bile salts via 7α-hydroxycholesterol”, “Synthesis of bile acids and bile 
salts”, “Bile acid and bile salt metabolism” and together with thioredoxin reductase (TXNRD1), 
glioma pathogenesis-related protein 1 (GLIPR1), connective tissue growth factor (CTGF), low density 
lipoprotein receptor (LDLR) in “Metabolism of lipids and lipoproteins”. A combination of genes 
TXNRD1, GLIPR1 and CTGF also played a role in “Regulation of Lipid Metabolism by Peroxisome 
proliferator-activated receptor alpha (PPARalpha)” and “PPARA Activates Gene Expression” 
pathways. AKR1C3 together with LDLR were also involved in “Retinoid metabolism and transport” 
and “Ovarian steroidogenesis”. 
“Keap1-Nrf2 Pathway” was enriched by heme oxygenase 1 (HMOX1) and glutamate-cysteine 
ligase regulatory subunit (GCLM) genes; HMOX1 also contributed together with TXNRD1 to 
“Oxidative stress” pathway enrichment and dominated as the only gene in the “Heme catabolic” 
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2.4.2. Functional Analysis
Co only odulated Pathways
e perfor ed functional analysis of significantly deregulated genes using the ToppFun tool
to discover co mon processes and pathways identically modified by all DEP extract treat ents.
Table 2 shows the rank of pathways enriched in the list of 27 common genes deregulated after 4 h
exposure. The top represented pathway was “Benzo[a]pyrene metabolism” with aldo-keto reductases
(AKRs) AKR1C3 and AKR1C2 as the most important contributing genes. It was the only pathway with
significance below 0.05 after Bonferroni correction. However, numerous other pathways were found
with high significance after False Discovery Rate Benjamini–Hochberg (FDR B&H) correction. AKR1C3
and AKR1C2 were further involved in “Synthesis of bile acids and bile salts via 27-hydroxycholesterol”,
“Synthesis of bile acids and bile salts via 24-hydroxycholesterol”, “Synthesis of bile acids and bile salts
via 7α-hydroxycholesterol”, “Synthesis of bile acids and bile salts”, “Bile acid and bile salt metabolism”
and together with thioredoxin reductase (TXNRD1), glioma pathogenesis-related protein 1 (GLIPR1),
connective tissue growth factor (CTGF), low density lipoprotein receptor (LDLR) in “Metabolism of
lipids and lipoproteins”. A combination of genes TXNRD1, GLIPR1 and CTGF also played a role in
“Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)”
and “PPARA Activates Gene Expression” pathways. AKR1C3 together with LDLR were also involved
in “Retinoid metabolism and transport” and “Ovarian steroidogenesis”.
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“Keap1-Nrf2 pathway” was enriched by heme oxygenase 1 (HMOX1) and glutamate-cysteine
ligase regulatory subunit (GCLM) genes; HMOX1 also contributed together with TXNRD1 to
“Oxidative stress” pathway enrichment and dominated as the only gene in the “Heme catabolic”
pathway. HMOX1 only contributed to the “Validated transcriptional targets of AP1 family members
Fra1 and Fra2”.
Urokinase-type plasminogen activator (PLAU) and serpin peptidase inhibitor, clade B (ovalbumin),
member 2 (SERPINB2) were genes contributing to over-representation of multiple pathways
(“Dissolution of Fibrin Clot”, “Fibrinolysis Pathway”, “Plasminogen activating cascade”, “Blood
clotting cascade”, “Blood coagulation” and together with IL24 in “Senescence and autophagy”). PLAU
itself further contributed to numerous pathways in cooperation with a variety of other genes such
as LDLR and BIK, BCL2-interacting killer (“DNA damage response (only ATM dependent)”), CTGF
(“amb2 Integrin signaling”), E2F transcription factor 2 (E2F2), fibroblast growth factor receptor 3
(FGFR3) and HMOX1 (“MicroRNAs in cancer”).
FGFR3 was the only gene contributing to “t(4;14) translocations of FGFR3” and together with
E2F2 was involved in “Bladder cancer”. Heat shock 27 kDa protein 1 (HSPB1) and stratifin (SFN) were
involved in “p38 signaling mediated by MAPKAP kinases” pathway enrichment.
Different responses were observed after 24 h incubation: fewer genes were shared by all treatments
and generally only several genes contributed to the deregulation of specific pathways (Table 3).
Among top ranked pathways belonged ”Benzo[a]pyrene metabolism” with the contribution of AKR1C2
and AKR1C4. These two genes also played a role in over-representation of other pathways such as
”Synthesis of bile acids and bile salts via 27-hydroxycholesterol”, ”Synthesis of bile acids and bile
salts via 24 hydroxycholesterol”, ”Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol”,
”Synthesis of bile acids and bile salts”, ”Bile acid and bile salt metabolism”, ”Steroid hormone
biosynthesis”, ”Metabolism of xenobiotics by cytochrome P450” and together with TXNRD1 and
3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) (HMGCS1) to ”Metabolism of lipids and
lipoproteins”. TXNRD1 was also important for ”thioredoxin pathway” and together with further
contribution of kynureninase (KYNU) and interleukin 1 beta (IL1B) for ”Selenium pathway”. COL7A1
and COL8A1 were genes involved in deregulation of ”Genes encoding collagen proteins”, ”Assembly
of collagen fibrils and other multimeric structures”, ”Collagen biosynthesis and modifying enzymes”,
”Collagen formation”. ”Protein digestion and absorption” was modulated due to the COL7A1 and
solute carrier family 3 (amino acid transporter heavy chain), member 2 (SLC3A2) action and ”ketone
bodies metabolic” due to HMGCS1.
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Table 2. Top ranked over-represented pathways shared by all DEP extract treatments following 4 h incubation. Functional enrichment was performed using ToppFun
tool integrating numerous annotation databases. Significant upregulation resp. downregulation of genes: ↑↓.
Name Genes from Input
”Benzo[a]pyrene metabolism”, ”Synthesis of bile acids and bile salts via
27-hydroxycholesterol”, ”Synthesis of bile acids and bile salts via 24-hydroxycholesterol”,
”Synthesis of bile acids and bile salts via 7α-hydroxycholesterol”, ”Synthesis of bile acids and
bile salts”, ”Bile acid and bile salt metabolism”
↑ AKR1C3, AKR1C2
”Metabolism of lipids and lipoproteins” ↑ TXNRD1, GLIPR1, AKR1C3, AKR1C2; ↓ LDLR, CTGF
”PPARA Activates Gene Expression”, ”Regulation of Lipid Metabolism by Peroxisome
proliferator-activated receptor alpha (PPARalpha) “ ↑ TXNRD1, GLIPR1; ↓ CTGF
”Retinoid metabolism and transport, Ovarian steroidogenesis” ↑ AKR1C3; ↓ LDLR
”Oxidative Stress” ↑ TXNRD1, HMOX1
”Keap1-Nrf2 Pathway” ↑ HMOX1, GCLM
”Validated transcriptional targets of AP1 family members Fra1 and Fra2” ↑ PLAU, HMOX1
”heme catabolic” ↑ HMOX1
”Dissolution of Fibrin Clot”, Fibrinolysis Pathway”, ”Plasminogen activating cascade”,
”Blood Clotting Cascade”, ”Blood coagulation” ↑ PLAU, SERPINB2
”Senescence and Autophagy” ↑ IL24, PLAU, SERPINB2
”amb2 Integrin signaling” ↑ PLAU; ↓ CTGF
”DNA damage response (only ATM dependent) “ ↑ PLAU, BIK; ↓ LDLR
”intrinsic apoptotic” ↑ BIK; ↓ BNIP3
”t(4;14) translocations of FGFR3” ↑ FGFR3
“Bladder cancer” ↑ FGFR3; ↓ E2F2
”MicroRNAs in cancer” ↑ PLAU, FGFR3, HMOX1; ↓ E2F2
”p38 signaling mediated by MAPKAP kinases” ↑ HSPB1, SFN
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Table 3. Top ranked over-represented pathways shared by all DEP extract treatments following 24 h incubation. Significant upregulation resp. downregulation of
genes: ↑↓.
Name Genes from Input
”Benzo[a]pyrene metabolism”, ”Synthesis of bile acids and bile salts via 27-hydroxycholesterol”,
”Synthesis of bile acids and bile salts via 24-hydroxycholesterol”, ”Synthesis of bile acids and bile salts
via 7α-hydroxycholesterol”, ”Synthesis of bile acids and bile salts”, ”Bile acid and bile salt metabolism”,
”Steroid hormone biosynthesis”, ”Metabolism of xenobiotics by cytochrome P450”
↑ AKR1C4, AKR1C2
”Metabolism of lipids and lipoproteins” ↑ TXNRD1, AKR1C4, AKR1C2; ↓ HMGCS1
”ketone bodies metabolic” ↓ HMGCS1
”Selenium Pathway” ↑ TXNRD1, IL1B, KYNU
”thioredoxin pathway” ↑ TXNRD1
”Genes encoding collagen proteins”, ”Assembly of collagen fibrils and other multimeric structures”,
”Collagen biosynthesis and modifying enzymes”, ”Collagen formation” ↑ COL7A1; ↓ COL8A1
”Protein digestion and absorption” ↑ COL7A1, SLC3A2
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Analysis of Variance
One-way ANOVA was employed to discover differently modulated gene expression levels across
all groups of treatment (NEXBTL100, B0, B30 and B100). After 4 h exposure, a significant alteration
in expression levels of 99 genes was found. The vast majority of detected genes was distinctively
modulated in response to NEXBTL100 compared to other treatments (Figure S1A). The functional
annotation of the NEXBTL100-specific gene set revealed genes associated with the regulation of
cell cycle. Genes involved in cell cycle (MCM8, RBL1, RPS27, CDC25C, ENSA, ZWINT) exhibited
elevated expression levels, while other regulators were rather suppressed (RAE1, CDKN2A, CCNB2).
The NEXBTL100 gene set further indicated the enhanced folding of actin by CCT/TriC (CCT6A, TCP1),
purine metabolism (ADSS, GART) and repressed expression levels of genes participated in oxidative
stress (HMOX1, TXNRD1, GPX1) or respiratory electron transport and mitochondrial function (CYC1,
UQCRFS1, NDUFV2, NDUFS3).
ANOVA also revealed significant differences in expression levels of 152 genes across all groups
of treatment upon 24 h incubation. We identified a distinctive pattern of modulated genes involved
in the regulation of cell cycle (KIF20A, AURKA, ACTR1A, UBA52, LMNA, CENPA, PSMC1, GINS2
or MCM4). Expression levels of these genes were almost exclusively elevated by NEXBTL100, while
the lowest levels were detected upon B0 and B30 treatment. Expression levels of RANBP1 and TPX2,
genes involved in Ran-mediated regulation of mitotic spindle assembly were lowest upon B0 treatment
compared to B30 displaying the highest potency to induce these genes (Figure S1B).
2.4.3. Quantitative RT-PCR Validation of Selected Genes
For verification of gene expression changes in microarray analysis, qRT-PCR of eleven selected
genes was performed (Figure 6). We focused on genes involved in processes and pathways related to
the metabolism of xenobiotics (AKR1C2, CYP1A1 and CYP1B1), activation of antioxidant defense
(HMOX1 and TXNRD1), AP-1 transcription, induction of plasminogen activator urokinase and
modulation of cell adhesion (FOSL1), modulation of cell cycle (CCNB2), apoptosis (CDKN2A and
BNIP3), regulation of spindle function (TPX2), endoplasmic reticulum stress and unfolded protein
response (HSPE1).
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Figure 6. Quantitative RT-PCR verification of gene expression data obtained by microarray analysis.
Eleven significantly deregulated genes were selected across all results and their gene expression levels
were determined using qRT-PCR. Gene expression changes (log2 FC) were obtained by normalization
to control samples (2−∆∆Ct method). Expression changes of selected genes upon: (A) 4 h exposure; and
(B) 24 h exposure. * Indicates a statistically significant difference (p-value < 0.05).
3. Discussion
In the present study, we aimed to reveal a molecular signature of the toxicity induced by different
organic compound mixtures extracted from diesel exhaust particles produced by diesel/renewable
fuels in human lung BEAS-2B cells. A comparative analysis of gene expression changes was used to
characterize the common mode of action underlying DEP extract exposure as well as specific effects of
individual DEP extract treatments.
Recent studies on the toxicity of different diesel and biodiesel exhaust particles suggest
inconsistent data due to different running conditions of engines and experimental approaches [23,24].
Here, we used a standardized procedure providing the same conditions for particle collection,
extraction and cell treatment thus enabling the accurate comparison of DEP extracts on gene expression
changes. Although in vitro exposure to whole particles is more relevant in terms of simulation of
real world conditions, many difficulties arising from intact particle collection, the characterization of
particles and their behavior in culture medium may consequently complicate the interpretation of
results. It has been documented that organic compounds bound to DEP are responsible to a large extent
for its genotoxicity and other effects [12,25]. To the best of our knowledge, a study investigating effects
of organic extracts from various fuels engine emissions on global gene expression changes in a model
cell line system has not been published yet, so comparable data are not available. However, several
authors reported the results of genotoxicity/mutagenicity of similar organic extracts. Bulky DNA
adduct formation in a cellular calf thymus DNA system was consistently increased after treatment of
the samples with extracts containing higher levels of PAHs [12,25]. In another study that investigated
mutagenic properties of organic extracts of diesel and biodiesel fuels, higher PAHs content was
associated with increased mutagenicity and bactericidal effects in Salmonella typhimurium TA98 and
YG1041 strains [19]. These reports are in line with our observation that application of NEXBTL100
extract that contains lower levels of PAHs results in weaker biological response. This suggests that not
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only genotoxicity/mutagenicity, but also global gene expression changes are strongly affected by the
presence of PAHs in the samples.
3.1. Common Cellular Response—4 h Cell Exposure
Despite the variability in chemical composition of individual DEP extracts, we revealed numerous
genes and pathways altered in the same manner. Commonly deregulated genes following 4 h exposure
were mostly involved in oxidative stress response and consequent events, such as activation of Nrf-2
and AP-1 transcription, antioxidant defense and DNA damage response.
The most significantly deregulated genes were AKR1C2 and AKR1C3. A wide substrate specificity
of these enzymes determines their implication in the metabolism of various exogenous and endogenous
compounds such as steroids, sugars, carbonyls and others. They have a dual role in toxicity: under
the control of Nrf-2 transcription factor they exhibit a detoxifying function by conversion of toxic
aldehydic products [26] or catalyze the NADPH-dependent reduction of the o-quinone products to
catechols and thus exacerbating ROS formation [27]. Induction of AKR1C1, 1C2 and 1C3 was also
observed in BEAS-2B cells exposed to urban particulate matter in the study of Longhin et al., 2016 [28].
Polycyclic aromatic hydrocarbons and other organic compounds are capable of producing a
substantial amount of ROS, which consequently lead to stabilization and activation of transcription
factor Nrf-2 and induction of antioxidants and detoxifying enzymes [27]. Nrf-2 participates
in the regulation of oxidant-stimulated functions, such as autophagy, inflammasome assembly,
ER stress/UPR, mitochondrial biogenesis or stem cell regulation as well as protects against toxicity
and chronic diseases in normal cells or through pharmacological interventions [29].
In our study, we observed elevated expression levels of HMOX1, GCLM and TXNRD1 suggesting
anti-oxidant response against ROS production. Surprisingly, we were not able to detect an increase in
ROS production by carboxy-H2DCFDA assay. The same effect was reported in the study of Li et al.,
2002 [30] where DEP extract treatment failed to induce DCF fluorescence in BEAS-2B, while the same
treatment and detection method was effective in different cells. However, the authors confirmed
the pro-oxidative potential by using a different method reflecting mostly production of superoxide
radical. They also demonstrated a decrease of the GSH/GSSG ratio in BEAS-2B cells but not in THP-1
macrophages, as well as increased expression of HMOX1, pro-inflammatory cytokine IL-8, activation
of JNK and decreased cell viability. In contrast, we observed no effect on reduced glutathione levels,
suggesting effective replenishment of depleted GSH stores possibly due to the enhanced expression of
GLCM. Moreover, other recent studies have demonstrated the pro-oxidative and pro-inflammatory
effect in BEAS-2B and other cell lines upon exposure to DEP chemicals [31]. Importantly, the authors
underscore the close relation of increasing oxidative potential of DEP extracts and the higher content
of PAHs.
An excessive amount of ROS can further activate intracellular signaling cascades, including the
mitogen-activated protein kinase. We detected significant upregulation of HSPB1, a protein chaperon
involved in stress resistance and regulation of apoptosis. HSPB1 maintains glutathione in its reduced
form and decreases the amount of reactive oxygen species (ROS) produced in cells exposed to oxidative
stress or tumor necrosis factor TNFα [32]. This could further support the hypothesis of a vigorous
antioxidant response, which effectively neutralizes ROS and restores GSH levels.
ROS generation by DEP extracts arising from enzymatic metabolism of organic compounds
as well as formation of reactive intermediates possibly cause DNA damage with consequent cell
cycle arrest, senescence and cell death. Our data strongly suggest activation of p53 signaling due
to the modulation of genes involved in “DNA damage response (ATM induced) pathway” (BIK,
LDLR, PLAU). We also observed the induction of SFN, a direct p53 effector, suggesting cell cycle
arrest in response to DNA double strand breaks. Suppression of CCNB2 by all extract treatments,
as confirmed by qRT-PCR, may indicate inhibition of cell cycle. It has been shown that the activity
of CCNB2, a key factor essential for transition from G2 to mitosis, is under the control of p53 which
represses transcription of CCNB2 and causes arrest in G2 phase upon DNA damage [33]. Elevated
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expression of GLIPR1, another p53 target, could further contribute to increased ROS production,
promote cell cycle arrest and apoptosis, as observed in prostatic cancer cells [34]. On the other hand,
pro-apoptotic BNIP3 was significantly downregulated by all treatments. This suppression of BNIP3
might be mediated by p53 acting in favor of the protection against hypoxia-induced cell death as
documented in Feng et al. [35]. Suppression of CDKN2A, a stabilizer of p53 protein, BIK and BNIP3
may suggest the suppression of p53 activity and anti-apoptotic response of the cells. FOSL1 induction
might be related to AP-1 transcription, induction of plasminogen activator urokinase (PLAU) and
modulation of cell adhesion [36]. Other genes contributing to DNA damage response indicated cellular
senescence and/or autophagy (PLAU, SERPINB2).
The role of plasminogen activator (PLAU) and its inhibitor (SERPINB2) in senescence is not fully
understood; however, the study of West et al. [37], described alterations in plasminogen activator
activity during replicative senescence leading to the disruption of extracellular matrix maintenance
with possible deleterious consequences on tissue homeostasis. According to our results, in the study
of Longhin et al. [28], the authors also found a strong induction of SERPINB2 and PLAU in BEAS-2B
cells exposed to whole airborne particles. Exposure to air pollution may cause acute exacerbation of
idiopathic pulmonary fibrosis [38]. Interestingly, enhanced expression of PLAU and SERPINB2 and
simultaneous suppression of CTGF, a growth factor promoting the fibrosis, observed in our study,
may suggest the anti-fibrotic response. Plasminogen activator and plasminogen activator-inhibitor are
components of the plasminogen activation system, which has been implicated in fibrosis reduction [39].
Similarly, a defensive role of Nrf2 target, TXNRD1, against fibrosis has also been described [40].
Moreover, activation of peroxisome proliferator-activated receptor α (PPARα) participating in the
processes of both physiological and toxicological response to various endogenous or exogenous
substances may also protect against lung fibrosis [41]. The multiple regulatory role of PPARα in various
processes related to oxidative stress, lipid metabolism and inflammation has been documented [42].
3.2. Differential Response Detected by Analysis of Variance—4 h Cell Exposure
A vast majority of genes detected by ANOVA among all treatments were distinctively modulated
in response to NEXBTL100 treatment and exhibited more than 1.5-fold change in expression
levels compared to a group median involving other gene sets (B0, B30 and B100). Most of the
NEXBTL100-specific genes were involved in DNA replication, cyclin B2 related events and entry into
mitosis. Elevated expressions of MCM8, RBL1, RPS27, CDC25C, ENSA and ZWINT may suggest
deregulation towards enhanced proliferation compared to other DEP extract treatment. Accordingly,
repression of RAE1, a mitotic checkpoint regulator, as well as CDKN2A, a tumor suppressor that
inhibits G1/S transition and establishes cell cycle arrest, could further support the hypothesis of
enhanced proliferative potential of NEXBTL100 extract.
Analysis of top-ranked over-represented pathways specific for each DEP extract treatment showed
that “Keap-Nrf2 pathway” and “Glutathione biosynthesis pathway” were the most significantly
affected by NEXBTL100 4 h exposure. However, NEXBTL100 induced the lowest levels of HMOX1,
TXNRD1 and GPX1 suggesting modest anti-oxidative response, possibly caused by the lowest
production of ROS. It should be stressed that changes were not significant compared to unexposed
controls. However, subtle changes in gene expression levels detected by ANOVA may also contribute to
distinctive gene expression patterns of individual DEP extracts treatments. These results indicate that
NEXBTL100 induced the weakest oxidative stress response and DNA damage and exhibited elevated
expression of genes possibly contributing to increased proliferation compared to other treatments.
On the other hand, the list of the most over-represented pathways modulated by B0, B30 and
B100 was similar to each other and involved “Benzo[a]pyrene metabolism” and similar pathways
(with AKR1C2 and CYP1B1 being the most contributing deregulated genes) and “Plasminogen
activating cascade” (with a significant contribution of SERPINB2, PLAU, PLAT). Additionally,
B100 extract, which contained the highest concentrations of carcinogenic PAHs, also affected most
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significantly the “Cell cycle”, “p38 signaling” and “Senescence and autophagy” pathways (data not
presented here).
3.3. Common Cellular Response—24 h Cell Exposure
The major toxic response following 24 h exposure to all DEP extracts was the metabolic activation
of PAHs. The key enzymes contributing to modulation of “Benzo[a]pyrene metabolism” and
“Metabolism of xenobiotics by cytochrome P450” as well as numerous other pathways were AKR1C2
and AKR1C4. AKRs participate in o-quinone pathway by conversion of PAH-diols into redox active
PAH o-quinones, but also facilitate the redox cycling of the PAH o-quinones to catechols. Catechols are
able to conjugate with a wide range of conjugating enzymes. Conjugation terminates the redox cycling,
eliminates formation of electrophilic products and prevents formation of covalent adducts [43]. We also
confirmed significantly elevated expression of other important PAH-metabolic enzymes CYP1A1 and
CYP1B1 by qRT-PCR, although microarray data did not indicate a significant increase, possibly due to
the high variability among replicates. CYP enzymes are involved in the formation of trans-dihydrodiols,
the first step of PAH activation and also in the consequent event when dihydrodiols are converted into
diol-epoxides, which can covalently bind to DNA and form persistent DNA adducts. The competing
role of CYP and AKR enzymes in the metabolic activation of PAH-diols has been observed in human
bronchoalveolar cell extracts [44].
The induction of CYP enzymes is dependent on the activation of AhR. Our recent data of
AhR-mediated activity performed in human AZ-AhR cells (Stable HepG2 Luciferase Reporter Cell
Line) by CALUX assay, suggest similar TEQ values for B0, B30 and B100 extracts and lower TEQ value
for NEXBTL100 extract (see Figure S2), which accordingly reflected a lower PAH content. The similar
trend could be also expected for BEAS-2B cell line. Our previous findings indicate that concentration
of PAHs in a mixture of organic compounds extracted from reference urban dust particulate matter is
higher [45] than in similar organic extracts from standard reference diesel exhaust particle material [25].
Therefore, also AhR-mediated activity of DEP extracts was lower. These results are in line with our
present findings where only partial induction of CYP1A1 and CYP1B1 mRNA confirmed the low
activation of the AhR-dependent gene expression. Interestingly, a recent study of Palkova et al.,
2015 [25] analyzing the toxicity of organic fraction extracted from reference material of diesel exhaust
particles (SRM 1650b) consistently evidenced its high AhR-inducing activity and potency to induce
metabolic enzymes, trigger DNA damage response and disrupt cell cycle progression and proliferation
in rat lung epithelial cells RLE-6TN and rat liver epithelial cells WB-F344 in the concentration range of
100–1000 and 50–1000 µg/mL, respectively, suggesting a higher potency to metabolize PAHs compared
to other cell lines.
Interestingly, a higher metabolic rate of organic compounds probably caused the interference
with WST-1 assay and gave false positive results of “enhanced” proliferation upon low dose exposures
to DEP extracts. Since WST-1 assay is based on conversion of tetrazolium dye by mitochondrial
dehydrogenases, the results obtained by WST-1 assay more likely imply enhanced metabolic activity
of cells due to the effect of organic compounds and not increased number of cells.
3.4. Differential Response Detected by Analysis of Variance—24 h Cell Exposure
Similar to 4 h incubation, ANOVA also revealed distinct gene expression patterns following 24 h
incubation across all treatments. Functional annotation of genes identified by ANOVA revealed that
the most distinctive signature was induced by NEXBTL100 extract treatment. Specifically, we found a
marked difference in expression levels of genes associated with regulation of chromosome segregation
and cytokinesis. Among them, AURKA is critical for the proper formation of mitotic spindle [46],
while CENPA controls kinetochore assembly and chromosome segregation [47] and KIF20A, a mitotic
kinesin, is required for chromosome passenger complex (CPC)-mediated cytokinesis [48]. It has been
demonstrated that p53 acts as a negative regulator of AURKA activity and reduces its expression level
after DNA damage [49]. Deletion of AURKA may consequently cause cell cycle arrest. AURKA requires
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a number of co-factors for its activation such as microtubule associated protein TPX2 and GTPase
Ran. Ran releases TPX2 to bind and activate AURKA by changing its conformation, stimulating
its autophosphorylation and targeting it to spindle microtubules at the pole [50]. Importantly,
overexpression of AURKA and TPX2 has been linked to tumor development at different levels [51].
We confirmed the elevated expression of TPX2 upon NEXBTL100 extract treatment by RT-qPCR, while
other treatments rather slightly suppressed gene expression level. TPX2 is an essential regulator of
spindle function and may indicate the possible negative effect of DEP extracts (excepting NEXBTL100)
on mitosis and generally on cell cycle progression [52].
3.5. Study Limitations
Although our study represents a comprehensive analysis of toxic effects of organic extracts from
various fuels engine emissions, there are several limitations that should be acknowledged.
The first limitation is related to the nature of the samples used for in vitro tests. The results
reported here are based on exposing the cells to the extracts from comparable masses of particles.
The results therefore represent the “quality” of the particles, expressed as some metric of effect per mg
of particulate matter, a metric suitable for attempting to comprehend the mechanisms of the effects
of particles on human health. For realistic evaluation of fuels, however, the effects of fuels should be
compared based on distance driven, amount of useful work performed by the engine, fuel consumed,
or similar metric. Since the total mass of particles emitted varied among the fuels (see Figure 1B), and
the effects are believed to be nonlinear, the results do not necessarily represent the realistic effects of
a fuel substitution on human health. In addition, due to the anticipated nonlinearity of effects with
respect to dose, expressing the effects per kg of fuel would be of limited use. The real exposure is not
to raw, undiluted exhaust, and the effective dilution ratio (reciprocal of the fraction of raw exhaust
in inhaled air) considerably varies with conditions (mainly proximity of vehicles to population and
atmospheric conditions). Evaluation of “realistic” fuel effects would therefore necessitate an arbitrary
and difficult to justify assumption of a certain dilution ratio.
Another limitation is the fact, that we used organic extracts rather than exhaust particles to
investigate biological effects of various fuel emissions. Although particles mediate some unique
effects, particularly oxidative stress induction that cannot be directly mimicked by extracts, organic
fraction contains PAHs, i.e., compounds with highest genotoxic activity and most immediate impact
on human health. It should be also noted that the use of organic extracts increase the bioavailability
of PAHs compared to whole particles experiments therefore the results may overestimate the effects
of DEP-associated PAHs. Oxidative stress induction measured in our study yielded mostly negative
results, although this may be caused by technical limitations of the test methods.
Finally, although gene expression profiling is a robust tool that covers simultaneously
whole-genome gene expression changes, it still measures a single endpoint (mRNA levels). To get more
insight into the mechanism of action of tested toxicant(s), gene expression profiling experiments should
be integrated into larger studies examining multiple end-points at the molecular, cellular, tissue, and
physiological levels in the context of the whole organism. Therefore, our study does not aim to reveal
the precise mechanism of action (e.g., cell cycle regulation or other fundamental cellular processes) but
rather provides new testable hypothesis that could be subsequently confirmed by further experiments.
4. Materials and Methods
4.1. Chemicals and Biochemicals
Bronchial Epithelial Basal Medium and BEGM™ BulleKit™ were purchased from Lonza
(Basel, Switzerland); Human bronchial epithelial cells BEAS-2B from ATCC (Manassas, VA, USA);
tert-butyl hydroperoxide, Glutathione Fluoriometric Assay Kit, NaHCO3, HEPES, and non-essential
amino acids were obtained from Sigma-Aldrich (St. Louis, MO, USA); WST-1 Proliferation Assay
and High Fidelity cDNA synthesis Kit from Roche (Mannheim, Germany); 5-(and-6)-carboxy-2′,
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7′-dichlorodihydrofluorescein diacetate and Hank’s Balanced Salt Solution from Thermo Fisher
Scientific (Waltham, MA, USA); NucleoSpin RNA II from Macherey-Nagel (Düren, Germany); Illumina
Human-HT12 v4 Expression BeadChips were from Illumina (San Diego, CA, USA); Illumina TotalPrep
RNA Amplification Kit from Ambion (Austin, TX, USA); RT-qPCR master mix, PerfectProbe assays and
geNorm Reference Gene Selection Kit from Primerdesign (Southampton, UK); Dulbecco’s Modified
Eagle’s Medium and Gentamicin Sulfate from Gibco (Paisley, UK) and Luciferase Assay kit from
BioThema (Handen, Sweden).
4.2. Test Vehicle and Exhaust Particles Collection
Engine tests and particle collection were performed on a transient engine dynamometer test
stand at the laboratories of the Czech Technical University in Prague in VTP Roztoky. An Iveco
Tector 5.9 L, 176 kW engine commonly used in the EU (and similar in design to Cummins ISB engine
used widely in the U.S.) was utilized as a representative of a common diesel engine of a small truck.
The engine was operated without after treatment to represent the type of engines responsible for
the majority of particulate matter in the air. Exhaust gases were transferred into a full-flow dilution
tunnel where the gases were mixed with fresh air filtered through active carbon and high-efficiency
particulate air (HEPA) filters. A constant volume sampler system kept the flow rate through the
dilution tunnel to 50 m3/min. DEP samples were taken from the dilution tunnel by two high volume
Ecotech 3000 samplers with installed impactor (cut off particle diameter 2.5 µm). The sample flow rate
was set to 67.8 m3/h. The samplers were normally used for atmospheric sampling and were modified
for use with diluted exhaust and subsequently augmented with an auxiliary three-stage blower to
increase the filter capacity. Borosilicate filters (8” × 10”, Emfab, TX40HI20-WW, Pall, Port Washington,
NY, USA) were used to collect hundreds of milligrams of DEP for the extraction procedure and toxicity
testing. The World Harmonized Transient Cycle (WHTC) used for type-approval of heavy-duty
engines was chosen as a test cycle. This cycle was run once with a cold start and nine times with a
hot start (it should be noted the engine was not fully warmed up after one WHTC). Four different
fuels were used: pure diesel (B0, Cepro, a.s., Prague, Czech Republic), neat fuel-grade biodiesel
(B100, methylesters of rapeseed oil, Cepro, a.s., Prague, Czech Republic), a blend of 70% B0 and 30%
B100 (v/v) mixed from B0 and B100, and pure hydrotreated vegetable oils and waste animal fats
(NEXBTL100, Neste Oil, Espoo, Finland). Before sampling, the engine ran 3 WHTC in order to adapt to
a new fuel. The engine was then left overnight at 23 ◦C as a preconditioning for the cold start WHTC
to prepare it for the sampling with a cold start the next day. DEPs collected within 10 WHTCs for every
fuel was used for chemical and toxicological analysis.
4.3. Particle Characterization and Chemical Analysis
Particle size distributions were measured using a fast mobility particle sizer (EEPS, Engine
Exhaust Particle Sizer, model 3090, TSI, St. Paul, MN, USA), coupled to a rotating disc microdiluter
(model MD-11, Matter Engineering Inc., Wohlen, Switzerland) set to a dilution ratio of 150:1, with the
dilution head heated to 150 ◦C. Fuel consumption was recorded using an AVL 735S Fuel Mass Flow
Meter (AVL, Graz, Austria).
Organic compounds from diesel exhaust particles produced by different fuels (B0, B30, B100 and
NEXBTL100 were extracted with 70 mL of dichloromethane in an automated extraction apparatus
(Behr EF, BEHR, Stuttgart, Germany) for 4 h (3 h in boiled solvent and 1 h in condensed solvent).
Requested aliquots of the extract were re-dissolved in required volume of acetonitrile for HPLC/DAD
and LC/MS-MS; and in dimethylsulfoxide (DMSO) for biological in vitro assays. Identification
of compounds was performed by comparison of their retention times with authentic standards.
The method of external standardization was used for quantification of contaminants. The accuracy and
precision of the analytical methods was determined by analyzing of the standard reference material
SRM 1650b (Diesel Particulate Matter, NIST, Gaithersburg, MD, USA). Further details on chemical
analysis are described elsewhere [45].
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4.4. Cell Cultures and Exposure Conditions
Human bronchial epithelial cells BEAS-2B were cultured in Bronchial Epithelial Basal Medium
(BEBM) supplemented with the standardized set of growth factors provided by the manufacturer
(BEGM™ BulleKit™). All cultivation flasks and plates were coated with BEBM containing fibronectin,
collagen and bovine serum albumin. All tested DEP extracts were diluted in complete BEBM and
cells were incubated in triplicates for 4 h or 24 h, respectively. Control cells were incubated with
DMSO extracts from blank filters. Cell cultures and cell-based assays were maintained in a humidified
atmosphere with 5% CO2 at 37 ◦C.
4.5. Cytotoxicity
To assess the viability of cells, the WST-1 Proliferation Assay was performed 24 h after exposure
to DEP extracts following the manufacturer’s protocol. BEAS-2B were cultivated in 96-well plates 24 h
before treatment in a density of 7500 cells per well. For dose–response curve and threshold cytotoxicity
assessment, cells were incubated in 18 concentrations (22–1000 µg/mL) of each DEP extract obtained
by serial dilution in BEGM. Positive controls were incubated with 0.1% Triton X-100 and negative
controls with complete medium.
4.6. Cell Culture Conditions, RNA Isolation and Quality Control
For gene expression profiling, cells suspended in complete BEBM were seeded in pre-coated Petri
dishes (surface area 22.1 cm2). Cell seeding density was 27,000 and 18,000 cells/cm2 for 4 and 24 h
exposure period, respectively. After 44 hours, media was removed, cells were washed with PBS and
3 mL of fresh dilutions of DEP extracts in complete BEBM (50 µg/mL) and controls (complete BEBM
and 0.1% DMSO) were added to the cells. Triplicates were prepared for each DEP extract and control.
Cells were incubated in humidified atmosphere with 5% CO2 at 37 ◦C for 4 and 24 h.
Total RNA from lysed BEAS-2B cells was obtained using NucleoSpin RNA II according to
the manufacturer’s instructions. RNA concentration was quantified with a Nanodrop ND-1000
Spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA). The integrity of RNA was assessed
using an Agilent 2100 Bioanalyzer (Agilent Technologies Inc., Santa Clara, CA, USA). All samples had
an RNA Integrity Number (RIN) greater than 9. Isolated RNA was stored at −80 ◦C until processing.
4.7. Microarray Analysis
Illumina Human-HT12 v4 Expression BeadChips were used to generate gene expression profiles.
Biotinylated complementary RNA (cRNA) was prepared from 200 ng of total RNA using the Illumina
TotalPrep RNA Amplification Kit (Thermo Fisher Scientific, Waltham, MA, USA). Next, 1000 ng
of biotinylated cRNA targets was hybridized to the beadchips. The steps of hybridization and the
subsequent washing, staining and drying of the beadchips were performed according to standard
instructions from Illumina. The hybridized beadchips were then scanned on the Illumina iScan
and bead level data were summarized by Illumina GenomeStudio Software v2011.1 (Illumina Inc.,
San Diego, CA, USA).
4.8. Real-Time Quantitative PCR (RT-qPCR) Verification
One microgram of RNA from each sample was used for complementary DNA (cDNA) synthesis
using the Transcriptor High Fidelity cDNA synthesis Kit (Roche, Basel, Switzerland). cDNA synthesis
was performed twice for each sample to obtain a technical replicate. The original protocol was
modified by using 2.5 µM oligo(dT) and 10 µM random hexamers for priming in a 20 µL reaction
volume. cDNA synthesis was run according to the following conditions: 30 min at 55 ◦C and 5 min at
85 ◦C. Quantitative PCR measurements were performed using the 7900HT Fast Real-Time PCR System
(Applied Biosystems, Carlsbad, CA, USA). Each RT-qPCR reaction was carried out in a final volume of
14 µL containing 3.5 µL of diluted cDNA, 2.8 µL of water and 7 µL of master mix. To determine the
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level of each target gene, 0.7 µL of a specifically designed assay (Custom designed real-time PCR assay
with Double-Dye probe, Primerdesign, Eastleigh, UK) was added to the reaction mixture. Cycling
conditions were: 2 min at 95 ◦C followed by 40 cycles of amplification (10 s at 95 ◦C and 60 s at 60 ◦C).
The baseline and threshold values of RT-qPCR experiments raw data were assessed with SDS Relative
Quantification Software version 2.3 (Applied Biosystems, Waltham, MA, USA) to determine Ct values.
Expression levels of target genes were normalized to the reference genes (B2M and ACTB). Reference
genes were selected according to the stability of gene expression during experimental conditions using
the geNorm Reference Gene Selection Kit. Relative changes in normalized gene levels were calculated
using the 2−∆∆Ct method [53]. The sequences of primers used in RT-qPCR are shown in Table S2.
4.9. Quantification of Intracellular ROS
The intracellular ROS levels upon DEP extracts treatments were detected by using
5-(and-6)-carboxy-2’,7’-dichlorodihydrofluorescein diacetate (carboxy-H2DCFDA). Cells were plated
into black 96-well plates one day before treatment in the density of 30,000 cells per well and each
measurement was performed using a cell triplicate. Before treatments, cells were loaded with Hank’s
Balanced Salt Solution containing 40 µM carboxy-H2DCFDA for 30 min. After dye loading, cells
were washed two times with BEGM and incubated with 50 µg/mL of each DEP extract or 250 µM of
tert-butyl hydroperoxide as a positive control for 4 h. Fluorescence was measured with a SpectraMax
M5 plate reader (Molecular Devices, Sunnyvale, CA, USA) with an excitation and emission wavelength
of 494 nm and 525 nm, respectively.
4.10. Quantification of Glutathione Levels
The total amount of reduced glutathione (GSH) in the cell cultures exposed to 50 µg/mL
of DEP extracts for 4 h was quantified with a Glutathione Fluorimetric Assay Kit according
to the manufacturer’s recommendations for a 96-well plate format. Absorbance was measured
by a SpectraMax M5 plate reader at 494 nm. Concentrations of reduced GSH were calculated
using a standard calibration curve; positive controls were treated with staurosporine (1 µg/mL).
Each measurement was performed using a cell triplicate.
4.11. Statistical Analysis
Gene expression levels were compared with control BEAS-2B cell cultures treated with extract
from blank filter only. Bead summary data were imported into R statistical environment (https:
//www.r-project.org/) and normalized using the quantile method in the Lumi package [54]. Only
probes with a detection p-value < 0.01 in more than 50% of arrays were included for further analyses.
Differential gene expression was analyzed in the Limma package using the moderated t-statistic.
A linear model was fitted for each gene given a series of arrays using lmFit function [55]. A multiple
testing correction was performed using the Benjamini and Hochberg method. To analyze lists of
significantly deregulated genes after DEP extract treatments (cut-off p-value < 0.05, fold change > 1.5,
or < 0.6), a ToppFun tool was used [56]. Functional analysis identified numerous over-represented
terms in several categories; pathways as a functional category were considered for the analysis.
The detection of differential gene expression was performed using the parametric one-way
ANOVA test. We employed the R Stats package [57] implementation using the design described in [58].
The p-values were adjusted for multiple comparisons using the BH method [59]. The Tukey’s “Honest
Significant Difference” method [60] served as a “post-hoc” test. The data of ROS generation, reduced
glutathione levels and expression of selected genes verified by RT-qPCR were expressed as mean
values ± S.D. To detect significant changes between means of treated groups and the control group,
the two-tail Student’s t-tests were used.
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5. Conclusions
In conclusion, equal concentrations of organic extracts of diesel and biodiesel exhaust particles
induced similar molecular response in BEAS-2B cells, although specific gene expression patterns
were also observed. Following 4 h exposure, we found altered processes related to oxidative stress
response (mostly antioxidant defense activation only), suppression of pro-apoptotic stimuli, regulation
of cell cycle and plasminogen activating cascade. NEXBTL100 extract distinctively exhibited a modest
antioxidant response, suggesting weaker stress response probably due to the less harmful nature of
the organic compounds compared to other extracts. The key common events after 24 h incubation
were metabolism of lipids and xenobiotics, including PAHs, and oxidative stress-induced pathways;
however, no increase in ROS production was detected. Importantly, no pro-inflammatory genes
(with the exception of IL24) and pathways were affected, cancer-related pathways were modulated
minimally and only a low AhR-mediated activity was found at sub-cytotoxic concentration of DEP
extracts. Biological effects of induction of plasminogen activating cascade (SERPINB2, PLAU and other
genes) in human bronchial cells should be further studied.
This study used the toxicogenomic approach to identify biological processes and pathways
affected by organic components of diesel exhaust particles produced by four commonly used fuels.
Although NEXBTL100 extract exhibited the weakest toxic response, our findings indicate subtle
differences in overall toxic effects induced by different diesel or alternative fuels’ DEPs, or their blends
when the equal amount of particles and qualitative composition of organic compound mixtures was
considered. Other factors, such as fuel consumption, total amount of produced particles or particle
size distribution may influence substantially the resulting toxic effects.
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